Literature DB >> 1279513

Serum bilirubin levels, intracranial hemorrhage, and the risk of developmental problems in very low birth weight neonates.

T M O'Shea1, R G Dillard, K L Klinepeter, D J Goldstein.   

Abstract

To study whether elevated levels of bilirubin in the neonatal period increase the risk of developmental problems for very low birth weight neonates, the investigators used data from a geographically based sample of 495 very low birth weight neonates, born January 1, 1985, to December 31, 1989, who survived to 1 year of adjusted age. Maximum neonatal bilirubin levels were found in medical records. A developmental problem was defined as either cerebral palsy or a Bayley Mental Developmental Index of less than 68 at 1 year adjusted age. Potentially confounding factors were controlled using logistic regression. To control for the effects of intracranial abnormalities (eg, intraventricular hemorrhage), separate logistic regression analyses were carried out for three strata, defined according to the results of cranial ultrasonography. In these analyses, the following odds ratios (with 95% confidence limits) were found for the association of maximum neonatal bilirubin concentration and developmental problems: for subjects without intracranial abnormalities, 0.9 (0.7, 1.9); for subjects with uncomplicated intracranial hemorrhage, 1.5 (0.8, 2.5); for subjects with complicated intracranial hemorrhage or intraparenchymal echo-densities, 1.2 (0.4, 3.6). In summary, in analyses controlled for confounding factors, maximum neonatal bilirubin level was not consistently associated with the risk of developmental problems identifiable at 1 year.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1279513

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

Review 1.  Jaundice in low birthweight infants: pathobiology and outcome.

Authors:  J F Watchko; M J Maisels
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-11       Impact factor: 5.747

2.  Sister Jean Ward, phototherapy, and jaundice: a unique human and photochemical interaction.

Authors:  M J Maisels
Journal:  J Perinatol       Date:  2015-06-11       Impact factor: 2.521

Review 3.  Newborn jaundice technologies: unbound bilirubin and bilirubin binding capacity in neonates.

Authors:  Sanjiv B Amin; Angelo A Lamola
Journal:  Semin Perinatol       Date:  2011-06       Impact factor: 3.300

Review 4.  Bilirubin Binding Capacity in the Preterm Neonate.

Authors:  Sanjiv B Amin
Journal:  Clin Perinatol       Date:  2016-02-28       Impact factor: 3.430

Review 5.  Treatment of jaundice in low birthweight infants.

Authors:  M J Maisels; J F Watchko
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-11       Impact factor: 5.747

6.  Aggressive vs. conservative phototherapy for infants with extremely low birth weight.

Authors:  Brenda H Morris; William Oh; Jon E Tyson; David K Stevenson; Dale L Phelps; T Michael O'Shea; Georgia E McDavid; Rebecca L Perritt; Krisa P Van Meurs; Betty R Vohr; Cathy Grisby; Qing Yao; Claudia Pedroza; Abhik Das; W Kenneth Poole; Waldemar A Carlo; Shahnaz Duara; Abbot R Laptook; Walid A Salhab; Seetha Shankaran; Brenda B Poindexter; Avroy A Fanaroff; Michele C Walsh; Maynard R Rasmussen; Barbara J Stoll; C Michael Cotten; Edward F Donovan; Richard A Ehrenkranz; Ronnie Guillet; Rosemary D Higgins
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

7.  Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants.

Authors:  W Oh; D K Stevenson; J E Tyson; B H Morris; C E Ahlfors; G Jesse Bender; R J Wong; R Perritt; B R Vohr; K P Van Meurs; H J Vreman; A Das; D L Phelps; T Michael O'Shea; R D Higgins
Journal:  Acta Paediatr       Date:  2010-01-25       Impact factor: 2.299

8.  Hyperbilirubinemia and neurodevelopmental outcome of very low birthweight infants: results from the LIFT cohort.

Authors:  Gaël Mazeiras; Jean-Christophe Rozé; Pierre-Yves Ancel; Gaëlle Caillaux; Anne Frondas-Chauty; Sophie Denizot; Cyril Flamant
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

9.  Evaluation of treatment thresholds for unconjugated hyperbilirubinemia in preterm infants: effects on serum bilirubin and on hearing loss?

Authors:  Christian V Hulzebos; Paula van Dommelen; Paul H Verkerk; Peter H Dijk; Henrica L M Van Straaten
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.